CIK 0000890821 · Non-accelerated filer<br>Smaller reporting company
Enveric Biosciences, Inc.
Sign in to watch- Ticker
- ENVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954484725
- Phone
- (617) 444-8400
- Business address
- 245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- AMERI Holdings, Inc., SPATIALIZER AUDIO LABORATORIES INC
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market buy Director bought 526 shares at $6.51 ($3,424)
- 8-K/A Event Acquisition or sale completed
- 4 Open-market buy Director bought 183 shares at $6.51 ($1,191)
- 4 Open-market buy Director bought 18,685 shares at $6.51 ($121,639)
- 4 Other acquisition Exec. Vice Chairman acquired 299,250 shares (other)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 1,094 shares at $6.51 ($7,122)
- 4 Open-market buy Director bought 450 shares at an average $6.51 ($2,929)
- 4 Open-market buy Director bought 1,023 shares at an average $6.41 ($6,559)
- 10-Q Report Quarterly Report
- 4 Open-market buy Director bought 124 shares at $6.51 ($807)
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale
- 4 Open-market buy Director bought 103 shares at $6.51 ($671)
- 4 Open-market buy Director bought 308 shares at $6.51 ($2,005)
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale
- 4 Open-market buy Director bought 200 shares at $6.51 ($1,302)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 36 of 53 · 1,057 filings